StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
TIRUMALCHM.NS$186.04-1.11%
Fair $186.04+0.0%

TIRUMALCHM.NS

Thirumalai Chemicals Limited

Basic Materials / Specialty ChemicalsNSE

$186.04

-2.09 (-1.11%)

Fairly Valued+0.0%Fair Value $186.04Fund rank 25/100 · Data gapFallback financials|
SA 11/F
F-Score: 1/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-5.7B · quality 37.3/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 21/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

11/100

F

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Revenue has declined for 2 consecutive years ROE is -4.0%, below the 5% threshold
Thesis & Journal · TIRUMALCHM.NSLocal privado en este navegador · Thirumalai Chemicals Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$22.4B

P/E

N/A

•

EV/EBITDA

54.2x

↑

ROE

-4.0%

↓

Gross Margin

21.1%

↑

Debt/Equity

1.55

↑
52-Week Range$186
$158$329

TradingView lightweight chart

TIRUMALCHM.NS price, volumen y niveles de valoración

Último $186.04Periodo +3685.1%
Fair value: $186.04

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.8%

FCF CAGR

—

FCF margin

-33.3%

FCF / Net income

14.72x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $20.37B · net income $-461.0M · FCF $-6.79B

2022-FY → 2025-FY

Gross margin

21.1%-17.8% pts

Operating margin

-0.2%-19.7% pts

Net margin

-2.3%-16.4% pts

FCF margin

-33.3%-49.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$20.37B$20.37B$20.72B$21.20B$19.88B
Net Income$-461.0M$-461.0M$-387.9M$898.3M$2.81B
EBITDA$647.3M$647.3M$645.4M$2.11B$4.49B
EPS-4.50-4.50-3.798.7727.46
Gross Margin21.1%21.1%18.7%26.5%38.9%
Operating Margin-0.2%-0.2%-0.3%6.2%19.5%
Net Margin-2.3%-2.3%-1.9%4.2%14.1%
Balance Sheet
Debt/Equity1.551.551.090.430.15
Cash Flow
Free Cash Flow$-6.79B$-6.79B$-5.74B$-3.09B$3.29B
Returns
ROE-4.0%-4.0%-3.4%7.5%25.9%
Valuation
P/E———21.3110.76
EV/EBITDA54.1954.1953.759.846.16
P/B1.651.652.291.612.79
Growth & Yield
Revenue Growth-1.7%-1.7%-2.3%6.6%—
EPS Growth-18.7%-18.7%-143.2%-68.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -24.7%

Total return

-24.7%

Start / end P/E

n/dx → n/dx

EPS bridge

-3.79 → -4.50

Residual

-24.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-24.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.